
Opinion|Videos|November 4, 2024
Outcome Measures in Generalized Myasthenia Gravis
Panelists discuss how various outcome measures are utilized in clinical practice to assess and monitor patients with generalized myasthenia gravis.
Advertisement
Video content above is prompted by the following:
- Can you talk about outcome measures in generalized myasthenia gravis and what you use in your practice?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Roche Unveils PrevenTRON, a Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High Risk of Alzheimer Decline
2
Alzheimer's Association Launches PROTECT-Cog Combination Prevention Trial
3
Sanofi's Oral TREM2 Agonist SAR448851 Advances to Phase 2 TREMHANCE Trial in Early Alzheimer Disease
4
Building the Foundation for Earlier Alzheimer Disease Diagnosis
5














